Promimic
10.80 SEK
0.00 %
Less than 1K followers
PRO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
0.00 %
-1.82 %
-8.86 %
-36.28 %
-10.37 %
-55.56 %
-43.16 %
-
-33.67 %
Promimic specializes in biotechnology. The company develops biocompatible surfaces for implants and conducts research in surface modifications. Examples of specialist areas include surface modifications for osseointegration for orthopedic and dental implants. The largest operations are in Europe and America, where research and development is conducted in-house but also through partners. Promimic is headquartered in Mölndal, Sweden.
Read moreMarket cap
204.04M SEK
Turnover
70.99K SEK
Revenue
44.42M
EBIT %
-17.33 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
19/5
2026
Interim report Q1'26
21/5
2026
General meeting '26
20/8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Promimic AB: Promimic anlitar ABG Sundal Collier som likviditetsgarant
Promimic AB: Promimic Årsredovisning för 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools